Retrieved from National Institutes of Health (NIH-a)
B12 is included for energy and because it is cheap, well tolerated and gives the injection a perceptible effect though only patients who are actually deficient should expect a real energy change from it
Studies show about 10% to 20% of patients drop out of trials because of these side effects, and more people stop the treatment in the "real world," outside of trials, where they likely get less support from doctors
It plays a critical role in appetite regulation, blood sugar control, and digestion
Younger adults ages 18 to 29 report a lower overall usage rate, at 10%
The agency won't cover GLP-1s for weight loss beginning July 1, though employees currently on those medications will be covered through the end of the year